[ScinoPharm] Announcement regarding the approval of the removal of non-compete restrictions for directors (including independent directors) and their representatives at the 116th Annual General Meeting

1. Date of Shareholders' Meeting: 2026/05/27 2. Names and titles of directors permitted to engage in competitive activities: [List of directors including Luo Chih-hsien, Kao Hsiu-ling, etc.] 3. Items of competitive activities: Business items identical to the company's scope of operations. 4. Period of permission: During the term of office as a director of the company. 5. Resolution details: In accordance with Article 209 of the Company Act, the removal of non-compete restrictions was approved without prejudice to the company's interests. 6. Directors involved in mainland China businesses: Chairman Luo Chih-hsien, Director Shih Chiu-ju, Independent Director Li Ming-hsien. 7. Positions held in mainland China: Chairman Luo holds various chairmanships and directorships in Uni-President related entities. Director Shih is a director at Kunshan Xingneng Energy. Independent Director Li is an independent director at Jin Yuan Uni-President Securities (Xiamen). 8. Locations and business scopes: Detailed list of addresses and business activities including food, beverages, lithium batteries, and securities. 10. Impact on financial and business operations: None. 11. Investment amount and shareholding ratio: None.